Shepherd Kaplan Krochuk LLC lifted its holdings in shares of Davita Inc (NYSE:DVA) by 10.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,500 shares of the company’s stock after buying an additional 3,297 shares during the period. Davita makes up about 1.3% of Shepherd Kaplan Krochuk LLC’s investment portfolio, making the stock its 9th largest holding. Shepherd Kaplan Krochuk LLC’s holdings in Davita were worth $2,543,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of DVA. California Public Employees Retirement System lifted its position in Davita by 8.6% in the second quarter. California Public Employees Retirement System now owns 571,830 shares of the company’s stock worth $39,708,000 after purchasing an additional 45,102 shares during the period. Hikari Tsushin Inc. lifted its position in Davita by 10.5% in the second quarter. Hikari Tsushin Inc. now owns 74,410 shares of the company’s stock worth $5,624,000 after purchasing an additional 7,050 shares during the period. Oppenheimer Asset Management Inc. acquired a new stake in Davita in the second quarter worth approximately $3,421,000. Tibra Equities Europe Ltd acquired a new stake in Davita in the second quarter worth approximately $1,627,000. Finally, Janus Henderson Group PLC lifted its position in Davita by 3.0% in the second quarter. Janus Henderson Group PLC now owns 1,284,092 shares of the company’s stock worth $89,168,000 after purchasing an additional 37,362 shares during the period. Institutional investors and hedge funds own 85.76% of the company’s stock.
A number of brokerages have recently commented on DVA. Zacks Investment Research upgraded Davita from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Monday, October 8th. Raymond James downgraded Davita from an “outperform” rating to a “market perform” rating and set a $63.44 price objective for the company. in a research report on Sunday, December 2nd. Royal Bank of Canada increased their price objective on Davita from $70.00 to $78.00 and gave the company a “sector perform” rating in a research report on Thursday, November 8th. UBS Group began coverage on Davita in a research report on Thursday, November 15th. They set a “sell” rating and a $64.00 price objective for the company. Finally, TheStreet downgraded Davita from a “b-” rating to a “c+” rating in a research report on Thursday, November 8th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the stock. Davita currently has a consensus rating of “Hold” and an average target price of $80.16.
Shares of NYSE:DVA traded down $1.70 on Friday, reaching $60.13. 219,201 shares of the company traded hands, compared to its average volume of 1,755,990. Davita Inc has a fifty-two week low of $58.68 and a fifty-two week high of $80.71. The company has a market capitalization of $10.64 billion, a PE ratio of 18.11, a price-to-earnings-growth ratio of 0.85 and a beta of 1.07. The company has a debt-to-equity ratio of 2.09, a quick ratio of 1.82 and a current ratio of 1.84.
Davita (NYSE:DVA) last announced its quarterly earnings data on Wednesday, November 7th. The company reported $0.56 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.33). Davita had a net margin of 5.39% and a return on equity of 13.87%. The company had revenue of $2.85 billion for the quarter, compared to analyst estimates of $2.93 billion. During the same quarter last year, the company posted $0.81 EPS. Davita’s revenue was up 3.0% on a year-over-year basis. As a group, research analysts forecast that Davita Inc will post 3.56 EPS for the current fiscal year.
WARNING: “Shepherd Kaplan Krochuk LLC Acquires 3,297 Shares of Davita Inc (DVA)” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/12/07/shepherd-kaplan-krochuk-llc-acquires-3297-shares-of-davita-inc-dva.html.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Article: How Do You Calculate Return on Equity (ROE)?
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.